Hirotaka Araki

LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation

Mitsuyoshi Nakao, Akihisa Sakamoto, Hirotoshi Tanaka, 2018, Nucleic acids research.

LSD1 acts as an epigenetic barrier against glucocorticoid-induced atrophy and exercise-induced hypertrophy in skeletal muscle

M. Nakao, E. Araki, Y. Ono, 2022, bioRxiv.

Distinct Roles of the NAD+-Sirt1 and FAD-LSD1 Pathways in Metabolic Response and Tissue Development

M. Nakao, S. Hino, Kotaro Anan, 2019, Trends in Endocrinology & Metabolism.

Direct and efficient verification of entanglement between two multimode–multiphoton systems

H. Hofmann, S. Takeuchi, R. Okamoto, 2020 .

Intermediate addition of reductant between an oxidation and a reduction catalyst for highly selective reduction of NO in excess oxygen

M. Iwamoto, Hirotaka Araki, Tetsu Zengyo, 1998 .

LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα.

M. Nakao, Tetsuya Sato, Akihisa Sakamoto, 2021, Blood advances.

Contributor Index Vol. 47, 2003

Vinicius Duval da Silva, M. Miyazaki, L. Pantanowitz, 2003, Acta Cytologica.

Subject Index Vol. 47, 2003

Vinicius Duval da Silva, M. Miyazaki, L. Pantanowitz, 2003, Acta Cytologica.

Papillary renal‐cell carcinoma demonstrating prominent foamy macrophages by cytobrush scrapings: A case report

T. Katsumori, R. Kushima, M. Ueda, 2000, Diagnostic cytopathology.

Lysine‐specific demethylase‐2 is distinctively involved in brown and beige adipogenic differentiation

M. Nakao, Taiping Chen, T. Nicholson, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Papillary Clusters as a Diagnostic Pitfall in Urinary Cytology of Pseudosarcomatous Fibromyxoid Tumor of the Bladder

S. Moritani, M. Ueda, Tadao K. Kobayashi, 2003, Acta Cytologica.